Facebook Linkedin Soundcloud Twitter Vimeo Xing
Home Tags Boltbody™ ISAC technology platform

Tag: Boltbody™ ISAC technology platform

U.S. Patent for Bolt Biotherapeutics’ Boltbody™ ISAC Platform Technology is a...

ADC Review | Editorial Team
San Francisco Bay Area-based Bolt Biotherapeutics confirmed that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 10,675,358 entitled "Antibody Adjuvant...
ADC Review, Journal of Antibody-drug Conjugates
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.

Latest

Peer Review

© 2013-2020 Sunvalley Communication, LLC. All Rights Reserved.

X